WOLF Grey Wolf Health Corp.

1.049USD1.500 CAD · TSXV-9.09%Mkt Cap: 36.32M USDP/E: 30.00

Grey Wolf Health Corp. operates as an animal health and wellness company in Canada. The company operates in two segments, Animal Health Business Unit and Pharmacy Business Unit. It engages in the sale, marketing, and dis…

Key Statistics

Company
Market Cap36.32M USD
Enterprise Value47.18M USD
Revenue (TTM)26.32M USD
Gross Profit13.33M USD
Net Income (TTM)1.16M USD
Revenue/Share0.77 USD
Last Price1.049 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryPharmaceutical Retailers
ISINCA39788G1000
Valuation
P/E (Trailing)30.00
P/E (Forward)30.00
PEG—
EV/EBITDA10.34
EV/Revenue1.79
P/S1.38
P/B1.64
EPS (TTM)0.03 USD
EPS (Forward)0.03 USD
52W Range
0.838946% of range1.293
52W High1.293 USD
52W Low0.8389 USD
Profitability
Gross Margin53.30%
Oper. Margin11.00%
EBITDA Margin17.34%
Profit Margin4.63%
ROE5.42%
ROA2.57%
ROIC5.84%
ROCE6.96%
Growth
Revenue Growth11.10%
Earnings Growth-33.70%
Cash Flow & Leverage
Operating CF2.68M USD
CapEx (TTM)362.88K USD
FCF Margin11.91%
FCF Yield8.63%
Net Debt10.86M USD
Net Debt/EBITDA2.38
Net Debt/FCF3.47
Balance Sheet
Debt/Equity0.83
Current Ratio2.74
Quick Ratio1.80
Book Value/Sh0.64 USD
Cash/Share0.18 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.573 USD
Upside (mean)+50.0%
Target Range1.573 USD – 1.573 USD
# Analysts1
Ownership
Shares Out.34.64M
Float26.49M
Insiders16.90%
Institutions13.80%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short112
Short (prev mo.)100
Technical
SMA 501.179 (-11.1%)
SMA 2001.122 (-6.6%)
Beta0.30
S&P 52W Chg12.00%
Avg Vol (30d)26.66K
Avg Vol (10d)17.28K
Technical Indicators
RSI (14)28.3
MACD-0.0252
MACD Signal-0.0141
MACD Hist.-0.0111
BB Upper1.239 USD
BB Middle1.165 USD
BB Lower1.092 USD
BB Width12.58%
ATR (14)0.0329 USD
Vol Ratio (20d)2.22x

About Grey Wolf Health (CVE: WOLF)

›

Grey Wolf Health (CVE: WOLF) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Pharmaceutical Retailers industry, part of the Healthcare sector.

The shares were at 1.500 CAD on 18 November 2026, up 25.0% over 52 weeks. Its 52-week range is 1.200 CAD to 1.850 CAD: the price is 18.9% below the high and 25.0% above the low.

At a market capitalisation of 51.96M CAD, it trades at 30.0 times trailing earnings and 30.0 times forward earnings. The median trailing P/E of its 4 largest Pharmaceutical Retailers peers is 25.0, a premium of 20% for WOLF.

Grey Wolf Health reports return on equity of 5.4%, an operating margin of 11.0% and revenue up 11.1% year over year.

Its debt exceeds its cash by 15.53M CAD, a debt-to-equity ratio of 0.83. Its Piotroski F-score is 9 out of 9, a strong reading of its financial health. One analyst covers the stock; their mean price target of 2.250 CAD is 50.0% above the current price. The next earnings report is expected on 19 November 2026.